Last reviewed · How we verify
Time in rANge vs. Time in nOrmal Glycemia for Better Glycemic Control (TANGO)
The TANGO study is a 12-month study involving 120 children and adolescents with Type 1 Diabetes (T1D) across the Czech Republic, Israel, and Poland who use automated insulin delivery (AID) systems. Currently, the global standard for diabetes management is "Time in Range" (TIR), which aims to keep blood sugar levels between 70-180 mg/dL. However, newer technologies like AID systems may now allow for a tighter, more physiological goal called "Time in Normal Glycemia" (TING), which targets a range of 70-140 mg/dL. This study will randomly assign participants to follow either the standard TIR target or the tighter TING target to see if the narrower range improves overall blood sugar control and HbA1c without increasing the risk of hypoglycemia, family stress, or daily treatment burden. By comparing these two approaches, researchers hope to determine if clinical guidelines should be updated to reflect a more precise glucose target for children and adolescents worldwide
Details
| Lead sponsor | University Hospital, Motol |
|---|---|
| Phase | NA |
| Status | NOT_YET_RECRUITING |
| Enrolment | 120 |
| Start date | 2026-01 |
| Completion | 2026-06 |
Conditions
- Diabetes
- Diabetes (DM)
- Diabetes Type 1
Interventions
- Structured Diabetes Education
- Automated Insulin Delivery (AID) System Adjustment
Primary outcomes
- Primary Endpoint — 12 months
Change in TIR over 12 months (between M0 and M12) between TING and TIR groups
Countries
Czechia, Israel, Poland